Documentation and Medicolegal Aspects — MCQs

10 questions

In the initial management of a hemodynamically unstable polytrauma patient, what is the recommended initial crystalloid bolus dose of Ringer's lactate for assessment and stabilization?

Certain obligations on the part of a doctor who undertakes a postmortem examination are the following, EXCEPT:

A 45-year-old female patient is told about the benefits and complications of a hysterectomy, and she agrees to the procedure. What kind of consent is this?

Which of the following is a non-ionic contrast agent?

To obtain adequate diagnostic imaging in a morbidly obese patient, what modification to X-ray technique is most important?

Contrast media of choice for a myelogram is

Q7Medium

All of the following are used in a patient with decreased renal function (reduced GFR) to avoid contrast nephropathy except?

Q8Easy

Which of the following conditions is associated with contrast nephropathy?

Q9Easy

Which of the following investigations must be performed before administering contrast to a patient?

Q10Easy

All of the following are true about iodinated intravascular contrast media except –

Documentation and Medicolegal Aspects Indian Medical PG Practice Questions and MCQs

Question 1: In the initial management of a hemodynamically unstable polytrauma patient, what is the recommended initial crystalloid bolus dose of Ringer's lactate for assessment and stabilization?

A. 2000 ml Ringer's lactate bolus
B. 1000 ml Ringer's lactate bolus, then regulated by clinical indicators (Correct Answer)
C. 250 ml Ringer's lactate bolus
D. 500 ml Ringer's lactate bolus, then regulated by clinical indicators

Explanation: ***1000 ml Ringer's lactate bolus, then regulated by clinical indicators*** - For **hemodynamically unstable** polytrauma patients, the initial recommended crystalloid bolus is typically **1 liter (1000 mL)** of Ringer's lactate. - This initial bolus allows for rapid assessment of the patient's response and guides subsequent fluid management based on **clinical indicators** such as blood pressure, heart rate, and urine output, avoiding over-resuscitation. *2000 ml Ringer's lactate bolus* - A **2000 ml bolus** is generally considered too large for an initial dose in trauma, as it can lead to **dilutional coagulopathy**, worsening hemorrhage, and **abnormal fluid shifts**, especially in cases where definitive hemorrhage control is not yet achieved. - Excessive fluid administration can lead to complications such as **abdominal compartment syndrome** and **acute respiratory distress syndrome (ARDS)**. *250 ml Ringer's lactate bolus* - A **250 ml bolus** is generally too small to effectively address **hemodynamic instability** in a polytrauma patient, offering insufficient volume to significantly improve circulation or organ perfusion. - While small boluses might be used in specific situations (e.g., small children or patients with cardiac comorbidities), this dose is not adequate for initial resuscitation in a severely unstable adult trauma patient. *500 ml Ringer's lactate bolus, then regulated by clinical indicators* - While **500 mL** is a common bolus size in other medical settings, it may be insufficient for the initial resuscitation of a **hemodynamically unstable adult polytrauma patient**. - Current trauma guidelines often recommend a larger initial bolus (e.g., 1000 mL) to gain a more immediate and measurable hemodynamic response for assessment.

Question 2: Certain obligations on the part of a doctor who undertakes a postmortem examination are the following, EXCEPT:

A. Routinely record all positive findings and important negative ones
B. He must keep the police informed about the findings (Correct Answer)
C. The examination should be meticulous and complete
D. He must preserve viscera and send for toxicology examination in case of poisoning

Explanation: ***He must keep the police informed about the findings*** - This is **NOT a formal obligation** of the doctor conducting a postmortem examination. - The doctor's primary duty is to conduct a thorough, objective examination and prepare a **formal postmortem report** that is submitted to the authority who requisitioned the examination (magistrate/police as per CrPC Section 174). - While findings may eventually reach the police through the official report, there is **no obligation to informally update or keep police informed** during the examination process. - The doctor's role is that of an **independent expert witness** to the court, not an investigative assistant to the police. - Maintaining independence and objectivity requires the doctor to document findings formally rather than providing ongoing informal updates to investigating officers. *Routinely record all positive findings and important negative ones* - This IS a **fundamental obligation** for any doctor performing a postmortem examination. - Both positive findings (pathological changes, injuries) and significant negative findings (absence of expected pathology) must be documented to provide a comprehensive and accurate record. - This meticulous documentation ensures the **integrity, reliability, and legal validity** of the postmortem examination and its conclusions. *The examination should be meticulous and complete* - This IS a **professional, ethical, and legal obligation** for any doctor undertaking a postmortem examination. - A systematic and thorough examination of all body systems is essential to accurately determine the cause of death and identify all relevant findings. - Incomplete examinations can lead to **missed diagnoses and miscarriage of justice** in medico-legal cases. *He must preserve viscera and send for toxicology examination in case of poisoning* - This IS a **crucial obligation** when poisoning is suspected or cannot be ruled out based on the postmortem findings. - Relevant viscera (liver, kidney, stomach contents) and bodily fluids (blood, urine) must be preserved in appropriate containers for subsequent toxicological analysis. - This step is **essential to confirm or exclude toxicological involvement** in the death and is a standard protocol in medico-legal postmortem examinations as per established guidelines.

Question 3: A 45-year-old female patient is told about the benefits and complications of a hysterectomy, and she agrees to the procedure. What kind of consent is this?

A. Informed consent (Correct Answer)
B. Implied consent
C. Opt-out consent
D. Passive consent

Explanation: ***Informed consent*** - This type of consent occurs when a patient is fully educated about the proposed treatment, including its **benefits, risks, and alternatives**, and voluntarily agrees to proceed. - It ensures the patient has adequate information to make an **autonomous decision** about their healthcare. *Implied consent* - This consent is inferred from a patient's **actions or conduct**, rather than being explicitly stated or written. - Examples include extending an arm for a blood draw or arriving at an appointment for a specific test. *Opt-out consent* - This model assumes agreement unless the individual explicitly **refuses or declines** participation. - It is commonly used in organ donation systems, where individuals are presumed donors unless they register otherwise. *Passive consent* - This usually refers to situations where explicit consent is not sought but also explicitly not denied, such as when parents are informed about a school health program and are given the opportunity to decline, but if they don't, consent is assumed. - It is less formal than informed consent and typically used for **low-risk interventions** or data collection.

Question 4: Which of the following is a non-ionic contrast agent?

A. Amidotrizoate
B. Iothalamate
C. Ioxoglate
D. Iohexol (Correct Answer)

Explanation: ***Iohexol*** - **Iohexol** is a well-known example of a **non-ionic, low osmolar contrast agent**. It's widely used due to its lower incidence of adverse reactions compared to ionic agents. - Non-ionic contrast agents remain as **intact molecules** in solution and do not dissociate into charged ions, contributing to their lower osmolality and better tolerability. *Amidotrizoate* - **Amidotrizoate** (also known as diatrizoate) is an **ionic, high osmolar contrast agent**. It dissociates into two ions in solution. - Due to its high osmolality, it is associated with a higher risk of adverse effects, such as **nausea**, **vomiting**, and **nephrotoxicity**. *Iothalamate* - **Iothalamate** is another example of an **ionic, high osmolar contrast agent**. It also dissociates into charged ions when dissolved. - Its use has decreased significantly with the development of safer non-ionic alternatives due to its higher potential for **adverse drug reactions**. *Ioxoglate* - **Ioxoglate** is a **dimeric, ionic contrast agent**. Although it's ionic, it has a lower osmolality than monomeric ionic agents due to its dimeric structure. - Despite being dimeric, it still dissociates into ions, distinguishing it from truly non-ionic compounds like iohexol.

Question 5: To obtain adequate diagnostic imaging in a morbidly obese patient, what modification to X-ray technique is most important?

A. Increase MAS
B. Decrease KVP
C. Increase KVP (Correct Answer)
D. Decrease MAS

Explanation: ***Increase KVP*** - Increasing the **kilovoltage peak (KVP)** is essential for imaging morbidly obese patients because it increases the **penetrating power** of the X-ray beam, allowing adequate transmission through thick body tissues. - Higher KVP (typically 90-120 kVp range) ensures the X-ray beam can penetrate increased soft tissue thickness and reach the image receptor with sufficient intensity. - While higher KVP produces **longer scale (lower) contrast**, it is necessary for adequate **penetration** in obese patients - without sufficient KVP, the image would be underexposed and non-diagnostic. - In practice, both KVP and MAS are increased for obese patients, but **KVP increase is more critical** for penetration. *Increase MAS* - Increasing **milliampere-seconds (MAS)** increases the quantity of X-ray photons and image density (brightness), which is also helpful for obese patients. - However, MAS alone without adequate KVP cannot solve the penetration problem - the photons would still be too low energy to penetrate thick tissues effectively. - MAS increase without KVP increase would result in high patient dose with poor image quality. *Decrease KVP* - Decreasing KVP reduces **beam penetration**, which would be catastrophic for imaging an obese patient. - The X-ray beam would be absorbed by superficial tissues, resulting in a severely **underexposed** and non-diagnostic image. - While lower KVP produces higher contrast in theory, it is completely inappropriate for thick body parts. *Decrease MAS* - Decreasing MAS reduces the number of X-ray photons, resulting in an **underexposed, lighter** image. - This would make it even more difficult to obtain adequate imaging through increased body mass, resulting in a non-diagnostic radiograph with excessive quantum mottle.

Question 6: Contrast media of choice for a myelogram is

A. Urografin 75%
B. Conray 470
C. Biligrafin
D. Iohexol (Correct Answer)

Explanation: ***Iohexol*** - **Iohexol** is a **non-ionic, low osmolality contrast medium** that is widely considered the contrast agent of choice for myelography due to its safety profile. - It has a lower incidence of neurotoxicity and adverse systemic reactions compared to older ionic contrast agents, making it suitable for direct injection into the **subarachnoid space**. *Urografin 75%* - **Urografin** contains **diatrizoate meglumine and sodium**, which are **ionic contrast agents**. - While suitable for intravenous urography, **ionic contrast agents are generally contraindicated for myelography** due to a higher risk of neurotoxicity, including seizures and arachnoiditis, when injected into the cerebrospinal fluid. *Conray 470* - **Conray 470** contains **iothalamate meglumine**, another **ionic contrast medium**. - Similar to Urografin, its **high osmolality and ionic nature** make it unsuitable for intrathecal administration for myelography, as it can cause significant neurotoxic effects. *Biligrafin* - **Biligrafin** is an **ionic, high osmolality contrast medium** primarily designed for **cholangiography**, typically administered intravenously to visualize the biliary tree. - It is **not used for myelography** due to its neurotoxicity risks and formulation, which is not intended for intrathecal injection.

Question 7: All of the following are used in a patient with decreased renal function (reduced GFR) to avoid contrast nephropathy except?

A. N-acetyl cysteine
B. Mannitol (Correct Answer)
C. Fenoldopam
D. Low osmolar contrast media (LOCM)

Explanation: **Explanation:** Contrast-Induced Nephropathy (CIN) is a significant risk in patients with reduced GFR. The goal of management is to minimize renal vasoconstriction and oxidative stress. **Why Mannitol is the Correct Answer:** Historically, diuretics like **Mannitol** and Furosemide were thought to "flush" the kidneys. However, clinical trials (such as the PRINCE study) have shown that Mannitol is **ineffective** and may actually be **harmful**. It can cause osmotic diuresis leading to dehydration and further renal vasoconstriction, potentially worsening the risk of CIN. Therefore, it is no longer recommended. **Analysis of Other Options:** * **N-acetyl cysteine (NAC):** An antioxidant that scavenges free radicals and induces vasodilation. While its efficacy is debated in recent large trials (PRESERVE), it is still traditionally used in protocols to prevent CIN due to its low cost and safety profile. * **Fenoldopam:** A selective dopamine D1 receptor agonist that causes renal vasodilation. Though not routinely used due to cost and mixed evidence, it is pharmacologically intended to increase renal blood flow. * **Low Osmolar Contrast Media (LOCM):** High osmolar contrast (HOCM) is highly nephrotoxic. Switching to LOCM (e.g., Iohexol) or Iso-osmolar contrast (e.g., Iodixanol) significantly reduces the risk of CIN in high-risk patients. **High-Yield Clinical Pearls for NEET-PG:** * **Most effective preventive measure:** Adequate **Pre-procedure Hydration** with 0.9% Normal Saline is the gold standard. * **Definition of CIN:** An increase in serum creatinine of >0.5 mg/dL or >25% from baseline within 48–72 hours of contrast administration. * **Metformin:** Must be withheld for 48 hours *after* the procedure to avoid lactic acidosis if renal failure occurs.

Question 8: Which of the following conditions is associated with contrast nephropathy?

A. Diabetes nephropathy (Correct Answer)
B. Hypertension
C. Malignant hypertension
D. Hypertensive glomerulosclerosis

Explanation: **Explanation:** **Contrast-Induced Nephropathy (CIN)** is defined as an acute impairment of renal function (an increase in serum creatinine by >25% or >0.5 mg/dL) occurring within 48–72 hours of intravascular contrast administration. **Why Diabetes Nephropathy is the Correct Answer:** Diabetes mellitus, particularly when associated with pre-existing renal insufficiency (**Diabetic Nephropathy**), is the **single most significant independent risk factor** for developing CIN. The pathophysiology involves contrast-induced renal vasoconstriction leading to medullary ischemia and direct tubular cytotoxicity. In diabetic patients, the baseline oxidative stress and impaired vasodilatory capacity of the renal vasculature significantly potentiate these effects. **Analysis of Incorrect Options:** * **B, C, and D (Hypertension, Malignant Hypertension, Hypertensive Glomerulosclerosis):** While chronic hypertension can lead to renal damage, it is generally considered a secondary risk factor. Hypertension only significantly increases the risk of CIN if it has already progressed to significant **chronic kidney disease (CKD)** with a reduced Glomerular Filtration Rate (GFR). Diabetic nephropathy carries a much higher relative risk compared to hypertensive nephrosclerosis alone. **High-Yield Clinical Pearls for NEET-PG:** * **Most Important Risk Factor:** Pre-existing renal insufficiency (low GFR). * **Most Effective Prophylaxis:** Intravenous hydration with **Isotonic Saline (0.9% NaCl)** or Sodium Bicarbonate before and after the procedure. * **Metformin Warning:** Metformin does not cause CIN, but if CIN occurs, Metformin can accumulate and cause **Lactic Acidosis**. It should be withheld for 48 hours after contrast administration. * **Contrast Choice:** Non-ionic, **iso-osmolar** contrast media (e.g., Iodixanol) carry the lowest risk for nephropathy.

Question 9: Which of the following investigations must be performed before administering contrast to a patient?

A. Kidney function test (KFT) (Correct Answer)
B. Liver function test (LFT)
C. Urine specific gravity
D. Serum electrolytes

Explanation: **Explanation:** The administration of iodinated contrast media (used in CT scans and angiography) poses a significant risk of **Contrast-Induced Nephropathy (CIN)**. CIN is defined as an acute decline in renal function (increase in serum creatinine by >0.5 mg/dL or >25% from baseline) within 48–72 hours of contrast exposure. Therefore, assessing the **Kidney Function Test (KFT)**—specifically **Serum Creatinine** and the **estimated Glomerular Filtration Rate (eGFR)**—is mandatory to screen for pre-existing renal impairment, which is the strongest risk factor for CIN. **Analysis of Incorrect Options:** * **Liver Function Test (LFT):** While some contrast agents are excreted via the biliary system, hepatic impairment does not significantly increase the risk of acute toxicity or contrast reactions. * **Urine Specific Gravity:** This measures urine concentration and hydration status but is an unreliable indicator of the kidney's ability to clear contrast media compared to eGFR. * **Serum Electrolytes:** While important for general patient management, electrolyte imbalances are not a direct contraindication to contrast nor a primary predictor of contrast-induced injury. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Threshold:** Contrast is generally considered safe if **eGFR >60 mL/min/1.73m²**. Caution is required if eGFR is between 30–60, and it is generally avoided (unless emergency) if **eGFR <30**. * **Prevention:** The most effective preventive measure for CIN is **intravenous hydration** with 0.9% Normal Saline before and after the procedure. * **Metformin:** In patients with renal impairment, Metformin should be withheld for 48 hours after contrast administration to prevent **Lactic Acidosis**. * **MRI Contrast:** For Gadolinium-based agents, the concern is **Nephrogenic Systemic Fibrosis (NSF)** in patients with severe renal failure.

Question 10: All of the following are true about iodinated intravascular contrast media except –

A. They are used in digital subtraction angiography
B. They are radio opaque
C. They can cause anaphylactic reactions
D. They are used in magnetic resonance imaging (Correct Answer)

Explanation: **Explanation:** The correct answer is **D**. Iodinated contrast media are specifically designed for X-ray-based imaging modalities, not Magnetic Resonance Imaging (MRI). **1. Why Option D is the correct (false) statement:** Iodinated contrast agents work by increasing the attenuation of X-ray beams due to the high atomic number of Iodine ($Z=53$). MRI does not use X-rays; instead, it utilizes magnetic fields and radiofrequency pulses. The standard contrast agents for MRI are **Gadolinium-based contrast agents (GBCAs)**, which are paramagnetic and work by altering the relaxation times ($T1$ and $T2$) of nearby water protons. **2. Analysis of incorrect (true) options:** * **Option A:** Digital Subtraction Angiography (DSA) uses iodinated contrast injected into vessels to visualize lumen morphology by "subtracting" the overlying bone and soft tissue densities. * **Option B:** Iodine is highly **radio-opaque** (appears white on imaging) because it absorbs X-ray photons, providing the necessary contrast against blood and soft tissues. * **Option C:** These agents can cause **idiosyncratic (anaphylactoid) reactions**, ranging from mild urticaria to life-threatening bronchospasm and shock. Unlike true allergies, these are often not IgE-mediated. **Clinical Pearls for NEET-PG:** * **Contrast-Induced Nephropathy (CIN):** A key risk factor; defined as an increase in serum creatinine >0.5 mg/dL or >25% from baseline within 48–72 hours of administration. * **Pre-medication:** For patients with a history of prior reactions, use corticosteroids (e.g., Prednisolone) and H1 blockers. * **Osmolality:** Non-ionic, low-osmolar contrast media (LOCM) are preferred over high-osmolar media (HOCM) as they are safer and better tolerated. * **MRI Exception:** While rare, **Hepatobiliary agents** (like Primovist) are used in MRI, but they are still Gadolinium-based, never iodinated.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free